Stephen Gucker

Array ( [id] => 1346413 [patent_doc_number] => 06579700 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'NPY family member' [patent_app_type] => B1 [patent_app_number] => 09/529727 [patent_app_country] => US [patent_app_date] => 2000-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4054 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579700.pdf [firstpage_image] =>[orig_patent_app_number] => 09529727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043746 [patent_doc_number] => 06867179 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-15 [patent_title] => 'Methods of inducing hair growth and coloration' [patent_app_type] => utility [patent_app_number] => 09/632748 [patent_app_country] => US [patent_app_date] => 2000-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 38 [patent_no_of_words] => 15932 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867179.pdf [firstpage_image] =>[orig_patent_app_number] => 09632748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1119488 [patent_doc_number] => 06797511 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-28 [patent_title] => 'Alarm related peptides and nucleic acids and diagnosis using them' [patent_app_type] => B1 [patent_app_number] => 09/629498 [patent_app_country] => US [patent_app_date] => 2000-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19195 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/797/06797511.pdf [firstpage_image] =>[orig_patent_app_number] => 09629498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1160445 [patent_doc_number] => 06759044 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Cryptopain antibodies for prophylaxis, treatment, diagnosis and detection of Cryptosporidium species' [patent_app_type] => B1 [patent_app_number] => 09/598062 [patent_app_country] => US [patent_app_date] => 2000-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 14427 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759044.pdf [firstpage_image] =>[orig_patent_app_number] => 09598062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1130008 [patent_doc_number] => 06787318 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer\'s disease pathology' [patent_app_type] => B1 [patent_app_number] => 09/585058 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15634 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787318.pdf [firstpage_image] =>[orig_patent_app_number] => 09585058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1588409 [patent_doc_number] => 06482608 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Cloning and recombinant production of CRF receptor(S)' [patent_app_type] => B1 [patent_app_number] => 09/580734 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27900 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482608.pdf [firstpage_image] =>[orig_patent_app_number] => 09580734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402910 [patent_doc_number] => 20020037277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Treatment of brain damage' [patent_app_type] => new [patent_app_number] => 09/537617 [patent_app_country] => US [patent_app_date] => 2000-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4387 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037277.pdf [firstpage_image] =>[orig_patent_app_number] => 09537617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1315887 [patent_doc_number] => 06608025 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-19 [patent_title] => 'Human NESP55 polypeptides, polynucleotides and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/468554 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19633 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608025.pdf [firstpage_image] =>[orig_patent_app_number] => 09468554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1171792 [patent_doc_number] => 06750012 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Method of identifying a psychotropic agent using differential gene expression' [patent_app_type] => B1 [patent_app_number] => 09/468253 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 30736 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750012.pdf [firstpage_image] =>[orig_patent_app_number] => 09468253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1323701 [patent_doc_number] => 06602708 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Neural cultures' [patent_app_type] => B1 [patent_app_number] => 09/454446 [patent_app_country] => US [patent_app_date] => 1999-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6983 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602708.pdf [firstpage_image] =>[orig_patent_app_number] => 09454446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 787959 [patent_doc_number] => 06986890 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-17 [patent_title] => 'Anti-human VEGF receptor Flt-1 monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 09/453718 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 50 [patent_no_of_words] => 43580 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/986/06986890.pdf [firstpage_image] =>[orig_patent_app_number] => 09453718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059746 [patent_doc_number] => 06852836 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-08 [patent_title] => 'Gene encoding brain-specific membrane protein' [patent_app_type] => utility [patent_app_number] => 09/831846 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11203 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852836.pdf [firstpage_image] =>[orig_patent_app_number] => 09831846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550842 [patent_doc_number] => 06399575 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Methods and compositions for targeting compounds to the central nervous system' [patent_app_type] => B1 [patent_app_number] => 09/438150 [patent_app_country] => US [patent_app_date] => 1999-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6246 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399575.pdf [firstpage_image] =>[orig_patent_app_number] => 09438150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4382884 [patent_doc_number] => 06277817 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Human lactoferrin' [patent_app_type] => 1 [patent_app_number] => 9/421632 [patent_app_country] => US [patent_app_date] => 1999-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12036 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277817.pdf [firstpage_image] =>[orig_patent_app_number] => 421632 [rel_patent_id] =>[rel_patent_doc_number] =>)